Last reviewed · How we verify

NCT07156474

Impact of Intraoperative Blood Pressure Components on Postoperative AKI: A Phenotype-Stratified Analysis

Not yet recruiting Last updated 5 September 2025
What this trial tests

trial in Postoperative Acute Kidney Injury in 44,504 participants. Not yet recruiting.

Timeline
9 September 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorLanyue Zhu
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment44,504
Start date9 September 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across China

Conditions studied

Sponsor

Lanyue Zhu

Who can join

18 and older, any sex, with Postoperative Acute Kidney Injury or Intraoperative Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative acute kidney injury (AKI) is a serious complication often linked to low blood pressure during surgery. This study aims to better protect patients' kidneys by personalizing how blood pressure is managed during an operation. The project has two main goals: First, researchers will analyze data from over 44,000 past surgeries to identify which specific blood pressure measurements are the most critical warning signs for kidney damage. Second, using this knowledge, they will build a smart tool (a machine learning model) to predict a unique, safe blood pressure target for each individual patient before their surgery begins. This personalized approach is intended to give doctors a specific target to maintain during surgery, helping to prevent kidney injury and improve patient safety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Acute Kidney Injury

Currently open trials in the same condition.

Other Lanyue Zhu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07156474.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing